A.-R. Hanauske
- Oncology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research
- Organic Chemistry
- Co-authors
- H. DepenbrockJ. WandersRobert PeterJosé JimenoJaap VerweijG. CatimelM. E. ScheulenChris Twelves
- Topics
- Lung Cancer Treatments and Mutations (9 papers)Cancer therapeutics and mechanisms (7 papers)Cancer Treatment and Pharmacology (7 papers)
- Partner nations
- GermanyNetherlandsUnited Kingdom
In The Last Decade
A.-R. Hanauske
43 papers receiving 678 citations
Peers
Comparison fields: 5 of 73
- Oncology 341
- Molecular Biology 308
- Pulmonary and Respiratory Medicine 214
- Cancer Research 103
- Organic Chemistry 81
Countries citing papers authored by A.-R. Hanauske
This map shows the geographic impact of A.-R. Hanauske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.-R. Hanauske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.-R. Hanauske more than expected).
Fields of papers citing papers by A.-R. Hanauske
This network shows the impact of papers produced by A.-R. Hanauske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.-R. Hanauske. The network helps show where A.-R. Hanauske may publish in the future.
Co-authorship network of co-authors of A.-R. Hanauske
This figure shows the co-authorship network connecting the top 25 collaborators of A.-R. Hanauske. A scholar is included among the top collaborators of A.-R. Hanauske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.-R. Hanauske. A.-R. Hanauske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 33 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 75 | |
| 6 | 13 | |
| 7 | 20 | |
| 8 | 16 | |
| 9 | 9 | |
| 10 | 83 | |
| 11 | 13 | |
| 12 | 27 | |
| 13 | 73 | |
| 14 | 46 | |
| 15 | 46 | |
| 16 | 2 | |
| 17 | 16 | |
| 18 | 11 | |
| 19 | 4 | |
| 20 | 28 |
About A.-R. Hanauske
A.-R. Hanauske is a scholar working on Biotechnology, Oncology and Pharmaceutical Science, having authored 43 papers that have together received 702 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Cancer therapeutics and mechanisms (7 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Otorhinolaryngology (69 citations), Oncology (341 citations) and Biotechnology (65 citations). A.-R. Hanauske has collaborated with scholars based in Germany, Netherlands and United Kingdom. Frequent co-authors include H. Depenbrock, J. Wanders, Robert Peter, José Jimeno, Jaap Verweij, G. Catimel, M. E. Scheulen, Chris Twelves, M. Roelvink and Alan Anthoney. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.